Lv1
96 积分 2024-04-22 加入
Clinical and Safety Outcomes of Edaravone Dexborneol in Acute Ischemic Stroke
2个月前
已完结
Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6–48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine (P2-11.016)
5个月前
已完结
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease
5个月前
已完结
皖公网安备34019202002308
